Global Growth in Anxiety and Panic Disorders Drugs Market 2017-2021 May 2017

Table of Contents of the Report PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction Key market highlights PART 05: Disease overview PART 06: Pipeline analysis PART 07: Market landscape Market overview Market size and forecast Five forces analysis PART 09: Geographical segmentation Anxiety and panic disorders drugs market in Americas Anxiety and panic disorders drugs market in EMEA Anxiety and panic disorders drugs market in APAC PART 10: Decision framework PART 11: Drivers and challenges Market drivers Impact of drivers on key customer segments Market challenges Impact of challenges on key customer segments PART 12: Market trends Synergistic effects of medication aided with neuromodulation devices Growing public awareness Evolving scientist’ s interest for development of novel therapeutics PART 13: Vendor landscape Competitive scenario PART 14: Key vendor analysis AstraZeneca Eli Lilly GlaxoSmithKline Pfizer Other prominent vendors

Global Growth in Anxiety and Panic Disorders Drugs Market 2017-2021 May 2017 | Page 2